Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins
Adriana Gutiérrez‐Hoya, Isabel Soto‐Cruz
Cells (2020) Vol. 9, Iss. 10, pp. 2297-2297
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
Bilal Rah, Rafiq A. Rather, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 133
Single‐Nucleus RNA Sequencing and Spatial Transcriptomics Reveal the Immunological Microenvironment of Cervical Squamous Cell Carcinoma
Zhihua Ou, Shitong Lin, Jiaying Qiu, et al.
Advanced Science (2022) Vol. 9, Iss. 29
Open Access | Times Cited: 76
Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk
Rehana Hewavisenti, Joshua Arena, Chantelle Ahlenstiel, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 59
miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses
Hesham A. El-Mahdy, Ahmed M. Mohamadin, Ahmed I. Abulsoud, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154457-154457
Closed Access | Times Cited: 51
An insight into the anticancer potentials of lignan arctiin: A comprehensive review of molecular mechanisms
Raihan Chowdhury, Md. Shimul Bhuia, Polrat Wilairatana, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32899-e32899
Open Access | Times Cited: 16
Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use
Yu Zhang, Ke Qiu, Jianjun Ren, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Rutin (Bioflavonoid) as Cell Signaling Pathway Modulator: Prospects in Treatment and Chemoprevention
Pratibha Pandey, Fahad Khan, Huda A. Qari, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1069-1069
Open Access | Times Cited: 68
Cellular landscaping of cisplatin resistance in cervical cancer
Rahul Bhattacharjee, Tanima Dey, Lamha Kumar, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113345-113345
Open Access | Times Cited: 54
Fisetin Deters Cell Proliferation, Induces Apoptosis, Alleviates Oxidative Stress and Inflammation in Human Cancer Cells, HeLa
Nazia Afroze, Sreepoorna Pramodh, Jasmin Shafarin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1707-1707
Open Access | Times Cited: 43
JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus
Arturo Valle‐Mendiola, Adriana Gutiérrez‐Hoya, Isabel Soto‐Cruz
Genes (2023) Vol. 14, Iss. 6, pp. 1141-1141
Open Access | Times Cited: 28
Targeting JAK2/STAT3 for the treatment of cancer: A review on recent advancements in molecular development using structural analysis and SAR investigations
Rupali Kohal, Priya Bisht, Ghanshyam Das Gupta, et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107095-107095
Closed Access | Times Cited: 15
Cancer Mutations Converge on a Collection of Protein Assemblies to Predict Resistance to Replication Stress
Xiaoyu Zhao, Akshat Singhal, Sungjoon Park, et al.
Cancer Discovery (2024) Vol. 14, Iss. 3, pp. 508-523
Open Access | Times Cited: 13
CRISPR integrated biosensors: A new paradigm for cancer detection
Ashok Saini, Neeraj Dilbaghi, Neelam Yadav
Clinica Chimica Acta (2025) Vol. 569, pp. 120179-120179
Closed Access | Times Cited: 1
Precision therapeutic targets for HPV-positive cancers: an overview and new insights
Yaw‐Bin Huang, Jiayi Wang, Wenbin Yang, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Extracellular HSP90α Induces MyD88-IRAK Complex-Associated IKKα/β−NF-κB/IRF3 and JAK2/TYK2−STAT-3 Signaling in Macrophages for Tumor-Promoting M2-Polarization
Chi-Shuan Fan, Chia‐Chi Chen, Lili Chen, et al.
Cells (2022) Vol. 11, Iss. 2, pp. 229-229
Open Access | Times Cited: 36
Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer
Chunnian Zhang, Liqin Gu, Juan Xiao, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 19
Unravelling infiltrating T‐cell heterogeneity in kidney renal clear cell carcinoma: Integrative single‐cell and spatial transcriptomic profiling
Haiqing Chen, Haoyuan Zuo, Jinbang Huang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 12
Open Access | Times Cited: 8
Cancer and HIV: The Molecular Mechanisms of the Deadly Duo
Aadilah Omar, N M Marques, Nicole Crawford
Cancers (2024) Vol. 16, Iss. 3, pp. 546-546
Open Access | Times Cited: 7
Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics
Tian‐Hua Wei, Meng‐Yi Lu, Sihui Yao, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Anticancer Potential of Flavonoids: Their Role in Cancer Prevention and Health Benefits
Yeonhee Pyo, Ki Han Kwon, Yeon Ja Jung
Foods (2024) Vol. 13, Iss. 14, pp. 2253-2253
Open Access | Times Cited: 6
Human Papillomavirus and Cellular Pathways: Hits and Targets
Alessandro Medda, Daria Duca, Susanna Chiocca
Pathogens (2021) Vol. 10, Iss. 3, pp. 262-262
Open Access | Times Cited: 34
Hypoxia Enhances HIF1α Transcription Activity by Upregulating KDM4A and Mediating H3K9me3, Thus Inducing Ferroptosis Resistance in Cervical Cancer Cells
Jing Xiong, Meifang Nie, Chun Fu, et al.
Stem Cells International (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 27
Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?
Yunyun Quan, Li Li, Zhujun Yin, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 25
Janus Kinase-Signal Transducer and Activator of Transcription Inhibitors for the Treatment and Management of Cancer
Fahim Anwar Rizwi, Md. Abubakar, Eswara Rao Puppala, et al.
Journal of Environmental Pathology Toxicology and Oncology (2023) Vol. 42, Iss. 4, pp. 15-29
Closed Access | Times Cited: 13
Molecular pathways and targeted therapies in head and neck cancers pathogenesis
Marian Constantin, Mariana Carmen Chifiriuc, Coralia Bleoţu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top